Phibro Animal Health in Pivotal Point Check: Animal Health Boom Drives 39% Revenue Increase – Stock Soars to All-Time High!
Reading Time: 2 minutes
Strong revenue and profit growth in Q4 surpasses expectations. Acquisition of Zoetis products in the area of medical feed additives significantly contributes to growth. The company provides an optimistic forecast for the upcoming fiscal year. Phibro Animal Health operates in the field of animal health and made headlines on August 28, 2025, with its financial results for Q4. The stock surged over 19%, reaching a new high of over $38. This impressive increase followed the release of a quarterly report that exceeded analysts' expectations...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
